EMEA-002599-PIP01-19

Key facts

Active substance
Zoliflodacin
Therapeutic area
Infectious diseases
Decision number
P/073/2020
PIP number
EMEA-002599-PIP01-19
Pharmaceutical form(s)
Granules for oral suspension
Condition(s) / indication(s)
Treatment of gonococcal infection
Route(s) of administration
Oral use
Contact for public enquiries
Entasis Therapeutic Inc.

E-mail: Enquiries@entasistx.com
Tel.: +1 7818108940

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating